Seqirus says can supply 60 million doses of influenza vaccines for U.S. flu season
(Reuters) – Vaccine maker Seqirus, a part of Australia-based biotech company CSL ltd, said on Tuesday it has started shipping
Read more(Reuters) – Vaccine maker Seqirus, a part of Australia-based biotech company CSL ltd, said on Tuesday it has started shipping
Read more